Advertisement

Blood Pressure Medication Recalled Over Cancer Risk

0

Recall due to the presence of nitrosamine impurities, classified as potential carcinogens

AEDs in Houses Improve Outcomes for Cardiac Arrest With Shockable Rhythm

0

Incremental cost-effectiveness ratio was $4,481,659 per quality-adjusted life-year for AED in a private home

Statins Not Tied to Cognitive Decline in Patients Receiving Doxorubicin

0

No worsening seen in cognitive function over 24 months among patients with lymphoma or breast cancer receiving doxorubicin

Radiofrequency Renal Denervation Lowers BP in CKD Stage 3a, b

0

Reductions seen in office systolic blood pressure for those in no-CKD, stage 3a CKD, and stage 3b CKD groups

~1 Percent of U.S. Docs Sponsored for H-1B Visas in Fiscal Year 2024

0

Counties with highest poverty level and rural counties had higher percentage of H-1B-sponsored physicians

Following MVPA Guidelines Provides Greater CHD Benefit for Women Than Men

0

CHD risk reduction of 30 percent reported with 250 minutes/week of MVPA for women, while men need 530 minutes/week for same benefits

Guidance Updated for CPR and Emergency Cardiovascular Care

0

Specific recommendations made for adult, pediatric, neonatal life support; resuscitation education; systems of care

Early Menopause Linked to Higher Risk for Metabolic Syndrome

0

27 percent increased relative risk for metabolic syndrome seen among women with early versus late menopause

Cardioprotective Effects of Semaglutide Independent of Adiposity

0

Greater waist circumference reduction at week 20 linked to lower subsequent MACE risk for those receiving semaglutide

Taking Most of Daily Steps in Longer Bouts Beneficial

0

Findings seen among persons taking fewer than recommended number of steps per day